Friedrich Stölzel

43PUBLICATIONS
350CO-AUTHORS
Major global burdens of diseaseApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursHaematologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Oct 05, 2026
Efficacy and safety of the ROCK2-inhibitor belumosudil for chronic GVHD: results from a multicenter retrospective analysis of a large German-Austrian cohort of the belumosudil MAP.

|Sep 10, 2026
Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party.

|Aug 18, 2026
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

|Jun 25, 2026
Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell Transplantation.

|Jun 12, 2026
Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

|Apr 14, 2026
Inhibition of high CXCR4 with motixafortide and absence of single-cell MRD predict outcome after AML consolidation.

Enise Ceran, Sonia Jaramillo, Anne Kathrin Merbach

Pageof 8

Frequent Collaborators

17 joint publications

Martin Bornhäuser

10 joint publications

Eva-Maria Wagner-Drouet

9 joint publications

Mohamad Mohty

8 joint publications

Uwe Platzbecker